StimLabs has announced the launch of Allacor P, a human umbilical cord device designed for acute and chronic wound management ...

When a typical day at the beach turned into a terrifying encounter with a shark, a teenage girl wondered if she’d ever be able to run track again. Doctors tried something unusual to heal her wounds: ...

StimLabs announces that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for Theracor, the first human ...

The Grande Ronde Hospital (GRH) Wound Clinic, located at 700 Sunset Dr., Suite F, has experienced significant growth over the past 15 years, evolving from a single-room clinic in the SurgiCenter that ...

Stimlabs LLC received U.S. FDA approval for Corplex P, a wound care product that uses placental tissue to facilitate wound healing. “Corplex P is the first particulate device derived from human ...

In Brazil, there is still no advanced therapy product for the treatment of chronic wounds and burns that has been registered with health regulatory bodies. A startup based at the Supera Innovation and ...

The FDA has warned birth tissue company Neobiosis that its products derived from human amniotic fluid and umbilical cord are unapproved drugs. In its warning letter to CEO Ian White, PhD, the FDA ...